home *** CD-ROM | disk | FTP | other *** search
- <ARTICLE>
- Date="04/19/95"
- Citation="60 FR 19608"
- Group="legal"
- Type="NOTICE"
- Department="DEPARTMENT OF JUSTICE"
- Agency="DRUG ENFORCEMENT ADMINISTRATION (DEA), JUSTICE"
- Subject="Established 1995 Aggregate Production Quota for a Schedule II Controlled Substance"
- <HEADER>
- DEPARTMENT OF JUSTICE
-
- Drug Enforcement Administration
-
- [DEA No. 129F]
-
- Established 1995 Aggregate Production Quota for a Schedule II
- Controlled Substance
-
- AGENCY: Drug Enforcement Administration (DEA), Justice.
-
- ACTION: Notice of an established 1995 aggregate production quota.
- </HEADER>
- DEPARTMENT OF JUSTICE
-
- Drug Enforcement Administration
-
- [DEA No. 129F]
-
- Established 1995 Aggregate Production Quota for a Schedule II
- Controlled Substance
-
- AGENCY: Drug Enforcement Administration (DEA), Justice.
-
- ACTION: Notice of an established 1995 aggregate production quota.
- +
- ------------------------------------------------------------
- SUMMARY: This notice establishes a 1995 aggregate production
- quota for hydrocodone (for conversion), a controlled substance
- in Schedule II of the Controlled Substances Act (CSA).
-
- DATES: This order is effective on April 19, 1995.
-
- FOR FURTHER INFORMATION CONTACT: Howard McClain, Jr., Chief,
- Drug & Chemical Evaluation Section, Drug Enforcement Administration,
- Washington, D.C. 20537, Telephone: (202) 307-7183.
-
- SUPPLEMENTARY INFORMATION: Section 306 of the Controlled Substances
- Act (CSA) (21 U.S.C. 826) requires that the Attorney General
- establish aggregate production quotas for controlled substances
- in Schedule I and II each year. This responsibility has been
- redelegated to the Deputy Administrator of the DEA pursuant
- to sec 0.104 of Title 28 of the Code of Federal Regulations.
-
- On February 13, 1995, a notice of the proposed 1995 aggregate
- production quota for hydrocodone (for conversion), a Schedule
- II controlled substance, was published in the Federal Register
- (60 FR 8251). All interested persons were invited to comment
- on or object to this proposed aggregate production quota on
- or before March 15, 1995. Comments were received from and a
- hearing on this matter was requested by one pharmaceutical company.
- The company maintains that the establishment of this aggregate
- production quota could have an impact on the United States and
- international narcotic raw material supply, since hydrocodone
- is derived from narcotic raw materials.
- Pursuant to the Code of Federal Regulations, Title 21, sec
- 1303.11(c), the Deputy Administrator may at his discretion hold
- a hearing on any issue relevant to the determination of an aggregate
- production quota. After review of all pertinent information,
- the Deputy Administrator has determined that no issue was found
- which warrants a hearing on this matter. Moreover, the proposed
- 2,200 kg of hydrocodone will not threaten the balance and supply
- of narcotic raw materials. Therefore the proposal for the 1995
- aggregate production quota for hydrocodone (for conversion)
- is adopted without change.
- The Office of Management and Budget has determined that notices
- of aggregate production quotas are not subject to centralized
- review under Executive Order 12866. This action has been analyzed
- in accordance with the principles and criteria in Executive
- Order 12612, and it has been determined that this matter does
- not have sufficient federalism implications to warrant the preparation
- of a Federalism Assessment.
- The Deputy Administrator hereby certifies that this action
- will have no significant impact upon small entities whose interests
- must be considered under the Regulatory Flexibility Act, 5 U.S.C.
- 601, et seq. The establishment of annual aggregate production
- quotas for Schedules I and II controlled substances is mandated
- by law and by international treaty obligations. While aggregate
- production quotas are of primary importance to large manufacturers,
- their impact upon small entities is neither negative nor beneficial.
- Accordingly, the Deputy Administrator has determined that this
- action does not require a regulatory flexibility analysis.
- Therefore, under the authority vested in the Attorney General
- by Section 306 of the Controlled Substances Act of 1970 (21
- U.S.C. 826) and redelegated to the Deputy Administrator by sec
- 0.104 of Title 28 of the Code of Federal Regulations, the Deputy
- Administrator of the DEA hereby orders that the 1995
-
- ---- page 19609 ----
-
- aggregate production quota for the following controlled substance,
- expressed in grams of anhydrous base, be established as follows:
-
-
-
-
- --------------------------------------------------------------+---------------
- | Established
- Basic class | 1995 quota
- | (in grams)
- --------------------------------------------------------------+---------------
- |
- Hydrocodone (for conversion) ................................ | 2,200,000
- --------------------------------------------------------------+---------------
-
- Dated: April 11, 1995.
-
- Stephen H. Greene,
- Deputy Administrator.
-
- [FR Doc. 95-9588 Filed 4-18-95; 8:45 am]
- BILLING CODE 4410-09-M
-
-
- ------------------------------------------------------
- The Contents entry for this article reads as follows:
-
- Schedules of controlled substances; production quotas:
- Schedule II-
- 1995 aggregate, 19608
- </ARTICLE>
-
- .
-